Pulmonary Thromboembolisms
17
5
5
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.9%
1 terminated out of 17 trials
87.5%
+1.0% vs benchmark
12%
2 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (17)
Electrical Impedance Tomography for Assessment of Pulmonary Hypertension
The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique
DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients
Functional Pulmonary Capillary Surface Area in BPA for CTEPH
Kidney Injury After PTE: Association With Hypothermic Circulatory Arrest Duration
Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism
Registry of Catheter Intervention in Pulmonary Embolism
Pulmonary Thromboembolism in Cancer Patients: Early Rule-out From the Emergency Department
Evaluation of the Effect of Drug-Related Problems in Pulmonary Embolism
Personalized Anticoagulant Therapy for Pulmonary Thromboembolism
OsciPulse Device for the Prevention of VTE
Machine Learning-based Models in Prediction of DVT and PTE in AECOPD Patients
Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE
Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension
Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events
Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease
Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD